U.S. Telecom Services and Carriers Stock News

Agree Realty (ADC) has drawn fresh attention after announcing a 3.6% increase in its monthly cash dividend and outlining a 2026 investment plan of up to US$1.5b for retail property acquisitions and developments. See our latest analysis for Agree Realty. At a share price of US$72.23, Agree Realty’s recent dividend increase and 2026 investment plan arrive after relatively muted share price movement over the past quarter. Its 1 year total shareholder return of 3.37% and 5 year total shareholder...

G-III Apparel Group (GIII) is back on investors’ radar after approving a quarterly dividend of US$0.10 per share and raising its fiscal 2026 earnings guidance following stronger-than-expected third quarter results. See our latest analysis for G-III Apparel Group. The dividend decision and upgraded fiscal 2026 guidance come as the share price trades at US$29.35, with a 9.03% 90 day share price return and a 77.69% three year total shareholder return. This suggests momentum has picked up...

Knight-Swift Transportation Holdings (KNX) just posted its fourth quarter 2025 results, reporting revenue of US$1,856.33 million and a net loss of US$6.8 million, compared with net income of US$69.5 million in the same period a year earlier. See our latest analysis for Knight-Swift Transportation Holdings. The weak fourth quarter and swing to a net loss sit against a share price of US$55.10, with a 90 day share price return of 23.02% and a 5 year total shareholder return of 39.16%. This...

Revolution Medicines recently dosed the first patient in its first-in-human trial of RMC-5127, an open-label study assessing safety, tolerability, pharmacokinetics and early antitumor activity in RAS G12V-mutated solid tumors after standard therapies have failed. The program targets RAS G12V, the second most common driver of RAS-addicted cancers in the US, affecting roughly 48,000 patients annually across pancreatic, colorectal and non-small cell lung cancers. We’ll now examine how the...

In recent months, Adecoagro has received a Zacks Rank #2 (Buy) as analysts sharply revised full-year earnings estimates higher and highlighted its value rating. What stands out is that Adecoagro’s valuation metrics, including P/E, PEG, P/B, and P/S ratios, compare favorably with its industry even as earnings expectations improve. We’ll now examine how this stronger earnings outlook, combined with favorable valuation ratios, shapes Adecoagro’s broader investment narrative for investors...

Trevi Therapeutics recently reported that key results from its Phase 2b CORAL trial of oral nalbuphine ER for chronic cough in idiopathic pulmonary fibrosis were published in the Journal of the American Medical Association, with safety outcomes broadly consistent with prior studies. The data showed similar discontinuation rates between nalbuphine ER and placebo and fewer serious adverse events in the nalbuphine ER group, underscoring a potentially differentiated safety profile. Next, we’ll...

In January 2026, UWM Holdings CEO Mat Ishbia indirectly sold 1,898,622 shares of Class A common stock for about US$11.14 million under a pre-arranged 10b5-1 trading plan, reducing his overall holdings while leaving his direct ownership unchanged. The scale and timing of these insider sales, against a backdrop of weak mortgage loan volumes, have intensified investor focus on UWM’s leadership intentions and longer-term corporate direction. We’ll now examine how Ishbia’s sizable insider sale...

WisdomTree, Inc. ( NYSE:WT ) has announced that it will pay a dividend of $0.03 per share on the 25th of February. This...

What recent performance says about Suburban Propane Partners Suburban Propane Partners (SPH) has seen mixed share performance recently, with a 1-day return of about a 1% decline contrasted against gains over the past week, month, and past 3 months. See our latest analysis for Suburban Propane Partners. That recent 1 day share price pullback sits against a 30 day share price return of 7.92% and a 90 day gain of 12.12%, while the 5 year total shareholder return of 91.12% shows how different the...

Cohen & Steers, Inc. reported past fourth-quarter 2025 results, with revenue rising to US$143.8 million from US$139.78 million a year earlier, while net income declined to US$34.88 million from US$45.82 million and diluted EPS from continuing operations eased to US$0.68 from US$0.89. This combination of higher revenue but lower profitability highlights shifting cost or business mix pressures that may be important for understanding the firm’s earnings quality. We will now examine how this mix...

Teva Pharmaceutical Industries (NYSE:TEVA) has drawn fresh attention after reporting full year 2025 earnings, moving from a prior net loss to US$1.4b in net income on US$17.3b in sales. See our latest analysis for Teva Pharmaceutical Industries. The recent earnings beat and return to profitability have gone hand in hand with a strong share price run, with a 90 day share price return of 66.57% and a 1 year total shareholder return of 96.43% suggesting momentum has been building over both...

With a price-to-sales (or "P/S") ratio of 10.1x Duos Technologies Group, Inc. ( NASDAQ:DUOT ) may be sending very...

Some say volatility, rather than debt, is the best way to think about risk as an investor, but Warren Buffett famously...

Polaris Inc. ( NYSE:PII ) has announced that it will be increasing its dividend from last year's comparable payment on...

Key Insights Using the 2 Stage Free Cash Flow to Equity, Core & Main fair value estimate is US$52.91 With US$53.36...

The board of Jacobs Solutions Inc. ( NYSE:J ) has announced that it will be paying its dividend of $0.36 on the 20th of...

Buying a low-cost index fund will get you the average market return. But in any diversified portfolio of stocks, you'll...

Ideally, your overall portfolio should beat the market average. But the main game is to find enough winners to more...

The Charles Schwab Corporation's ( NYSE:SCHW ) dividend will be increasing from last year's payment of the same period...

When a single insider purchases stock, it is typically not a major deal. However, when multiple insiders purchase...

Key Insights Institutions' substantial holdings in Kemper implies that they have significant influence over the...

Some say volatility, rather than debt, is the best way to think about risk as an investor, but Warren Buffett famously...

Exponent (EXPO) heads into its February 5 earnings report with analysts expecting higher revenue and a year over year earnings increase, and the Most Accurate Estimate sitting above the broader consensus. See our latest analysis for Exponent. Exponent’s share price has recently been choppy, with a 7 day share price return of a 4.6% decline, a 30 day share price return of 2.5%, and a current price of US$71.87. Its 1 year total shareholder return shows a 20.5% decline, which points to weaker...

In late January 2026, Raytheon announced a multi-year agreement with TTM Technologies worth up to US$200 million over three years to supply radio frequency assemblies, electronic hardware and printed circuit boards for its Lower Tier Air and Missile Defense Sensor program. The deal, alongside TTM’s move from the S&P SmallCap 600 to the S&P MidCap 400, highlights the company’s growing role in defense electronics and its rising profile among mid-cap index investors. With this expanded Raytheon...